A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
CareDx completed the sale of its lab products business to Eurobio Scientific on June 30, 2026, and received $171.2 million in ...
Zacks Investment Research on MSN
CareDx completes Naveris acquisition and expands oncology reach
CareDx CDNA recently completed the acquisition of Naveris, expanding its presence in high-growth specialty oncology. The ...
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio’s strategic ...
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
Abstract: Breath analysis and monitoring have emerged as pivotal components in both clinical research and daily health management, particularly in addressing the global health challenges posed by ...
The detection and characterization of human leukocyte antigen (HLA) antibodies are central to assessing immunological risk in transplantation. While conventional HLA antibody testing has traditionally ...
As a clinical laboratory technician certified in transfusion medicine, I work in transfusion, immunology, and hematology testing at a general hospital. Have you ever experienced a situation in ...
Members of the HLA’s Horticulture Crops Weed Science Lab recently published three peer-reviewed research articles. Greenhouse evaluation of napropamide and pendimethalin for suppression of strawberry ...
According to MarketsandMarkets, the Transplant Diagnostics Market is projected to grow from about USD 5.61 billion in 2026 to USD 8.14 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results